These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38636896)

  • 1. Metronomic chemotherapy in hematology: Lessons from preclinical and clinical studies to build a solid rationale for future schedules.
    Banchi M; Cox MC; Bocci G
    Cancer Lett; 2024 Jun; 591():216900. PubMed ID: 38636896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metronomic chemotherapy regimens and targeted therapies in non-Hodgkin lymphoma: The best of two worlds.
    Cox MC; Bocci G
    Cancer Lett; 2022 Jan; 524():144-150. PubMed ID: 34673128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metronomic chemotherapy for cancer treatment: a decade of clinical studies.
    Romiti A; Cox MC; Sarcina I; Di Rocco R; D'Antonio C; Barucca V; Marchetti P
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):13-33. PubMed ID: 23475105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential clinical promise of 'multimodality' metronomic chemotherapy revealed by preclinical studies of metastatic disease.
    Kerbel RS; Shaked Y
    Cancer Lett; 2017 Aug; 400():293-304. PubMed ID: 28202353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of acquired resistance to metronomic oral topotecan chemotherapy plus pazopanib after prolonged preclinical potent responsiveness in advanced ovarian cancer.
    Cruz-Muñoz W; Di Desidero T; Man S; Xu P; Jaramillo ML; Hashimoto K; Collins C; Banville M; O'Connor-McCourt MD; Kerbel RS
    Angiogenesis; 2014 Jul; 17(3):661-73. PubMed ID: 24569856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metronomic chemotherapy: A relook at its basis and rationale.
    Rajasekaran T; Ng QS; Tan DS; Lim WT; Ang MK; Toh CK; Chowbay B; Kanesvaran R; Tan EH
    Cancer Lett; 2017 Mar; 388():328-333. PubMed ID: 28003122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical analysis of resistance and cross-resistance to low-dose metronomic chemotherapy.
    Chow A; Wong A; Francia G; Man S; Kerbel RS; Emmenegger U
    Invest New Drugs; 2014 Feb; 32(1):47-59. PubMed ID: 23728939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metronomic reloaded: Theoretical models bringing chemotherapy into the era of precision medicine.
    Benzekry S; Pasquier E; Barbolosi D; Lacarelle B; Barlési F; André N; Ciccolini J
    Semin Cancer Biol; 2015 Dec; 35():53-61. PubMed ID: 26361213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metronomic chemotherapy from rationale to clinical studies: a dream or reality?
    Gnoni A; Silvestris N; Licchetta A; Santini D; Scartozzi M; Ria R; Pisconti S; Petrelli F; Vacca A; Lorusso V
    Crit Rev Oncol Hematol; 2015 Jul; 95(1):46-61. PubMed ID: 25656744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metronomic chemotherapy and immunotherapy in cancer treatment.
    Chen YL; Chang MC; Cheng WF
    Cancer Lett; 2017 Aug; 400():282-292. PubMed ID: 28189534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metronomic chemotherapy in metastatic colorectal cancer.
    Woo IS; Jung YH
    Cancer Lett; 2017 Aug; 400():319-324. PubMed ID: 28274890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot study of a pediatric metronomic 4-drug regimen.
    André N; Abed S; Orbach D; Alla CA; Padovani L; Pasquier E; Gentet JC; Verschuur A
    Oncotarget; 2011 Dec; 2(12):960-5. PubMed ID: 22156656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metronomic and metronomic-like therapies in neuroendocrine tumors - Rationale and clinical perspectives.
    Lambrescu I; Fica S; Martins D; Spada F; Cella C; Bertani E; Rubino M; Gibelli B; Grana C; Bonomo G; Funicelli L; Ravizza D; Pisa E; Zerini D; Ungaro A; Fazio N;
    Cancer Treat Rev; 2017 Apr; 55():46-56. PubMed ID: 28314176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective treatment of advanced human melanoma metastasis in immunodeficient mice using combination metronomic chemotherapy regimens.
    Cruz-Munoz W; Man S; Kerbel RS
    Clin Cancer Res; 2009 Aug; 15(15):4867-74. PubMed ID: 19622578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metronomic therapy concepts in the management of adrenocortical carcinoma.
    Berruti A; Sperone P; Bellini E; Daffara F; Perotti P; Ardito A; Saini A; Terzolo M
    Horm Cancer; 2011 Dec; 2(6):378-84. PubMed ID: 21971765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metronomic chemotherapy using orally active carboplatin/deoxycholate complex to maintain drug concentration within a tolerable range for effective cancer management.
    Mahmud F; Chung SW; Alam F; Choi JU; Kim SW; Kim IS; Kim SY; Lee DS; Byun Y
    J Control Release; 2017 Mar; 249():42-52. PubMed ID: 28093298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of vascular normalization in benefit from metronomic chemotherapy.
    Mpekris F; Baish JW; Stylianopoulos T; Jain RK
    Proc Natl Acad Sci U S A; 2017 Feb; 114(8):1994-1999. PubMed ID: 28174262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer.
    Kamat AA; Kim TJ; Landen CN; Lu C; Han LY; Lin YG; Merritt WM; Thaker PH; Gershenson DM; Bischoff FZ; Heymach JV; Jaffe RB; Coleman RL; Sood AK
    Cancer Res; 2007 Jan; 67(1):281-8. PubMed ID: 17210709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect.
    Bocci G; Kerbel RS
    Nat Rev Clin Oncol; 2016 Nov; 13(11):659-673. PubMed ID: 27184418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.